- Home
- COYA
as 03-31-2025 4:00pm EST
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 108.4M | IPO Year: | 2022 |
| Target Price: | $17.00 | AVG Volume (30 days): | 91.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.75 - $10.24 | Next Earning Date: | 03-18-2025 |
| Revenue: | $3,554,061 | Revenue Growth: | -40.79% |
| Revenue Growth (this year): | 61.45% | Revenue Growth (next year): | -11.12% |
Latest Coya Therapeutics Inc. News
COYA Breaking Stock News: Dive into COYA Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
What Makes Coya Therapeutics, Inc. (COYA) a New Buy Stock
Zacks
4 days ago
Wall Street Analysts Think Coya Therapeutics, Inc. (COYA) Could Surge 149.62%: Read This Before Placing a Bet
Zacks
4 days ago
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Business Wire
5 days ago
Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program
Simply Wall St.
11 days ago
Coya Therapeutics (NASDAQ:COYA) Is In A Good Position To Deliver On Growth Plans
Business Wire
13 days ago
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results
Business Wire
a month ago
Coya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer’s Disease Using GLP-1 Agonists and Combinations
Benzinga
2 months ago
Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers Following Monthly Dosing
Compare COYA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COYA Coya Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.